Clinical Trials Logo

Epilepsy clinical trials

View clinical trials related to Epilepsy.

Filter by:

NCT ID: NCT00567424 Withdrawn - Epilepsy Clinical Trials

GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Start date: July 2006
Phase: Phase 2
Study type: Interventional

Study to determine drug interactions between GW273225 and the anticonvulsants valproate, carbamazepine or phenytoin

NCT ID: NCT00566046 Terminated - Clinical trials for Epilepsy, Post-Traumatic

Prevention of Post-traumatic Seizures With Levetiracetam

TRACK
Start date: November 2007
Phase: Phase 3
Study type: Interventional

Post-traumatic seizures can appear frequently after a severe traumatic brain injury. Two types of seizures are usually identified: early seizures during the week following the trauma and late epilepsy afterward. Several antiepileptic drugs are usually used to prevent early seizures but no treatment has demonstrated any preventive effect against late epilepsy. Levetiracetam is an antiepileptic drug usually used for the treatment of epileptic patients and has pharmacologic properties that could also be interesting for the prevention of post-traumatic epilepsy.

NCT ID: NCT00564915 Completed - Epilepsy Clinical Trials

RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

Start date: December 2001
Phase: Phase 4
Study type: Interventional

A study of the efficacy and tolerability of two different ketogenic diets in children with drug resistant epilepsy; children resistant to at least two drugs randomised to reveive diet after baseline or after further 3m control period; in addition randomised to either MCT or classical ketogenic diet.

NCT ID: NCT00563459 Terminated - Epilepsy Clinical Trials

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Start date: November 2007
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to compare the long term effectiveness, safety and tolerability of carisbamate compared to two other frequently prescribed anti-epileptic drugs (AEDs) in patients with epilepsy.

NCT ID: NCT00559169 Withdrawn - Catamenial Epilepsy Clinical Trials

Verapamil and Catamenial Epilepsy

Start date: February 2009
Phase: N/A
Study type: Interventional

One in 3 epilepsy patients have refractory seizures. This drug resistance is likely related to the over expression of multidrug resistance proteins (MDR). Progesterone is a known inhibitor of MDRs and the low level of this hormone during the menstrual cycle may exacerbate seizures, perhaps explaining catamenial epilepsy; i.e. seizures occurring during the menstrual cycle. Verapamil suppresses seizures in animal models of epilepsy perhaps by inhibiting MDRs and thus may help patients with refractory seizures. If the study shows improved seizure control, the results will help establish the role of MDRs in refractory epilepsy.

NCT ID: NCT00552526 Active, not recruiting - Epilepsy Clinical Trials

Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy

Start date: November 2007
Phase: Phase 4
Study type: Interventional

This is an open randomized controlled study in children with mental retardation and refractory epilepsy in which treatment with ketogenic diet (KD) is compared with treatment with the antiepileptic drug (AED), not tried by the patient before, which we consider to be the most appropriate AED for the patient.

NCT ID: NCT00552045 Completed - Epilepsy Clinical Trials

Epilepsy Phenome/Genome Project

EPGP
Start date: November 2007
Phase:
Study type: Observational

The purpose of this study is to collect detailed information about the characteristics and genetics of a large number of individuals with epilepsy.

NCT ID: NCT00550940 Completed - Epilepsy Clinical Trials

Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children With Epilepsy

Start date: July 2007
Phase: N/A
Study type: Observational

This study aims to Investigate characteristics and prevalence of emotion/behavior problems in child and adolescents with epilepsy; to identify the associated factors and their effects on these children/adolescents; and to examine their attention by using Conners' Continuous Performance Test (CPT).

NCT ID: NCT00544050 Completed - Epilepsy Clinical Trials

Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

Start date: September 2002
Phase: Phase 2
Study type: Interventional

The primary purpose of this study was to document the pharmacokinetic parameters of both levetiracetam and its metabolite, ucb L057, after a single dose of 20 mg/kg of levetiracetam in epileptic pediatric subjects, aged 1 month to less than 4 years.

NCT ID: NCT00543322 Terminated - Healthy Clinical Trials

PET Study of the Nicotinic Receptors in Human

Start date: July 2001
Phase: Phase 1/Phase 2
Study type: Observational

The purpose of this study is to quantify the brain distribution of the nicotinic receptors in human volunteers and their alterations in patients suffering from neurological diseases such as Parkinson and Alzheimer diseases and familial epilepsy. This will be done using Postron Emission Tomography (PET) and a new radiotracer of the nicotinic receptors.